Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05702749 · ClinicalTrials.gov registry record · NA
Evaluating Pre-Treatment Vestibular Physical Therapy Rehab for Patients with Vestibular Schwannomas
A NA study of Vestibular Schwannoma, sponsored by Medical College of Wisconsin.
- Recruiting
- Registry status
- NA
- Development phase
- 36
- Enrollment target
- 1
- Study location
NCT05702749 is a NA study of Vestibular Schwannoma that is actively recruiting participants, run by Medical College of Wisconsin. The registered enrollment target is 36 participants, below the 47-participant average among 7 other Vestibular Schwannoma trials with a reported enrollment target (23% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05702749, a NA study of Vestibular Schwannoma, is actively recruiting participants, sponsored by Medical College of Wisconsin.
- RECRUITING
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
- 1
- Study location
Study Summary
The study is a pilot efficacy study. The investigators aim to estimate mean baseline and post-treatment balance scores among Vestibular Schwannomas (VS) patients undergoing pretreatment rehab (PREHAB) or no PREHAB when managed with either surgery or radiosurgery.
Conditions Studied
Interventions
- PROCEDURE Microsurgical resection of VS
- RADIATION Stereotactic radiosurgery
- OTHER PREHAB
Study Locations (1)
Wisconsin
- Froedtert Hospital and the Medical College of Wisconsin - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2024-01-22 |
| Est. Completion | 2027-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05702749
The ClinicalTrials.gov registry entry for NCT05702749 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 47-participant average among 7 other Vestibular Schwannoma trials with a reported enrollment target (23% lower). The listed sponsor is Medical College of Wisconsin, which has 447 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Vestibular Schwannoma appearing as the primary indexed condition, and to 3 interventions - of which Microsurgical resection of VS is the first listed.
NCT05702749 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.
Frequently Asked Questions
What is clinical trial NCT05702749 about?
NCT05702749 is a clinical study titled "Evaluating Pre-Treatment Vestibular Physical Therapy Rehab for Patients with Vestibular Schwannomas". The study is a pilot efficacy study. The investigators aim to estimate mean baseline and post-treatment balance scores among Vestibular Schwannomas (VS) patients undergoing pretreatment rehab (PREHAB) or no PREHAB when managed with either surgery or radiosurgery.
What is the current status of trial NCT05702749?
This trial is currently recruiting. It is a NA study. The enrollment target is 36 participants. The study started on 2024-01-22. Estimated completion is 2027-12.
What conditions does trial NCT05702749 study?
This clinical trial studies the following conditions: Vestibular Schwannoma.
What interventions are being tested in trial NCT05702749?
The interventions under investigation include: Microsurgical resection of VS (PROCEDURE), Stereotactic radiosurgery (RADIATION), PREHAB (OTHER).
Who is sponsoring clinical trial NCT05702749?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05702749 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vestibular Schwannoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
StableEyes With Active Neurofeedback
RECRUITING · NA
-
CI Following VS Removal or Labyrinthectomy
RECRUITING · NA
-
Anti-VEGF Gene Therapy Trial for Vestibular Schwannoma
RECRUITING · Phase 1
-
Hearing Outcomes Using Fractionated Proton Radiation Therapy for Vestibular Schwannoma
ACTIVE NOT RECRUITING · Phase 2
-
Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)
ACTIVE NOT RECRUITING · Phase 2
-
Study of Aspirin in Patients With Vestibular Schwannoma
ACTIVE NOT RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.